Parkinson's Disease Trial, Recruiting NCT06906276 Sponsor: Karolinska Institutet Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06906276
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been clinically diagnosed with Progressive Supranuclear Palsy (PSP) based on established medical guidelines (2017 criteria)
  • People who have been clinically diagnosed with Multiple System Atrophy (MSA) based on established medical guidelines (2022 criteria)
  • People who are able to walk for up to 5 minutes continuously, with or without a walking aid such as a cane or walker

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have cognitive difficulties that affect their ability to understand or follow spoken or written instructions
  • People who experience severe "freezing" episodes while walking (where movement suddenly stops or becomes very difficult to start)
  • People with severe hearing or vision problems that would make it difficult to participate in the assessments
  • People who have other neurological conditions in addition to PSP or MSA
  • People who have other health conditions that affect their ability to walk or maintain balance

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Franziska Albrecht, PhD, Karolinska Institutet

Phone: +46852480000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 March 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Functional near infrared spectrometry (fNIRS); Gait performance during all conditions; Dual-task performance-reaction time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov